Stock AnalizOmnicell, Inc. OMCL
Computer Manufacturing · IPO 2001 · data as of November 13, 2026
Omnicell, Inc. (OMCL) is a technology company listed in the US with a market value of about $1.6B. In the twelve months to September 30, 2026 it had revenue of $1.2B and net income of $45M, a net margin of 3.6%.
Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is financial health (5/5); the weakest is track record (0/5).
Key numbers: a P/E of 36.5, a price to free cash flow of 11.1, 5-year revenue growth of 6% a year, a 5-year average ROIC of 0%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 55% below the current price.
Score: 2.2 / 5
Checks passed
- P/FCF below 20
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.1B | $1.3B | $1.1B | $892M | $897M | $787M | $713M | $696M |
| Net income | $45M | $2M | $13M | -$20M | $6M | $78M | $32M | $61M | $38M | $31M | $10M |
| Free cash flow | $146M | $87M | $151M | $140M | $30M | $203M | $163M | $129M | $80M | $9M | $36M |
| EPS (diluted) | $0.96 | $0.04 | $0.27 | $-0.45 | $0.12 | $1.62 | $0.74 | $1.43 | $0.93 | $0.79 | $0.26 |
| Net margin | 3.6% | 0.2% | 1.1% | -1.8% | 0.4% | 6.9% | 3.6% | 6.8% | 4.8% | 4.3% | 1.4% |
| ROIC | — | 0.3% | 0.0% | -2.2% | -0.2% | 4.2% | 2.7% | 6.8% | 3.9% | 1.1% | 2.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 7 analysts is $57.43, 64% above the current price; targets range from $50.00 to $68.00; the consensus rating is “Strong buy”; expected EPS is $2.48 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Omnicell’s P/E ratio?
About 36.5, based on the last twelve months of diluted earnings per share (forward P/E about 18.6).
Is Omnicell stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 55% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Omnicell pay a dividend?
Not currently.
Is Omnicell a good stock to buy?
We do not give buy or sell advice. Omnicell scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.